Daniel Thomas Ginat

University of Chicago

Papers

2

Total Citations

75

H-Index

2

About

No biography available yet.

Research Focus

Immunotherapy2 · 75 citations
Cancer2 · 75 citations
Oncology2 · 75 citations
Nivolumab2 · 75 citations
Chemotherapy2 · 75 citations
Medicine2 · 75 citations
Internal medicine2 · 75 citations
Breast cancer1 · 45 citations
Complete response1 · 45 citations
Neoadjuvant therapy1 · 45 citations
Clinical trial1 · 30 citations
Clinical endpoint1 · 30 citations

Key Achievements

2
H-Index
2
Papers
75
Total Citations
38
Avg Citations/Paper
🏆 Most Cited Paper
Neoadjuvant Nivolumab Plus Chemotherapy Followed By Response-Adaptive Therapy for HPV<sup>+</sup> Oropharyngeal Cancer
45 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 22
🏛 Institutions: University of Chicago

Top Papers

  1. 1
    Neoadjuvant Nivolumab Plus Chemotherapy Followed By Response-Adaptive Therapy for HPV<sup>+</sup> Oropharyngeal Cancer
    45 citations · 2024
  2. 2
    Nivolumab, nabpaclitaxel, and carboplatin followed by risk/response adaptive de-escalated locoregional therapy for HPV-associated oropharyngeal cancer: OPTIMA II trial.
    30 citations · 2021

Key Collaborators

AJAri J. Rosenberg2 shared papersATAlexander T. Pearson2 shared papersZGZhen Gooi2 shared papersEAElizabeth A. Blair2 shared papersTYTanguy Y. Seiwert2 shared papersNANishant Agrawal2 shared papersAJAditya Juloori2 shared papersDJDaniel J. Haraf2 shared papersEIEvgeny Izumchenko2 shared papersJCJeffrey Chin2 shared papersEEEverett E. Vokes2 shared papersFSFrederick S. Jones1 shared papersNANicole A. Cipriani1 shared papersAHAdam Howard1 shared papersJCJohn Cursio1 shared papersSKSara Kochanny1 shared papersOPOlga Pasternak-Wise1 shared papersASAnna Starus1 shared papersEMEllen MacCracken1 shared papersRWRachelle Wolk1 shared papers
Not generated yet